Cryptosporidium Parvum
Morphology |
Is an intracellular protozoan parasite. It has a complex lifecycle with sexual and
asexual cycles taking place in a single host. Oocysts are thick-walled and are the
extracellular and environmental stage.
|
---|---|
Disease |
Cryptosporidiosis
|
Zoonosis |
Oocysts. Acquired through contact with contaminated animal fecal matter, particularly diarrhea. |
Host Range |
Humans and animals.
|
---|---|
Modes of Transmission |
Transmitted through the fecal-oral route, direct contact with infected humans or animals,
contaminated food, water, and aerosols.
|
Signs and Symptoms |
Acute gastroenteritis. Symptoms include diarrhea, abdominal pain, cramps, fever, vomiting,
myalgia, nausea, anorexia, malaise, and fatigue.
|
Infectious Dose |
As low as 1-5 oocysts.
|
Incubation Period |
7 to 10 days.
|
Prophylaxis | None available. |
---|---|
Vaccines | None available. |
Treatment |
None.
|
Surveillance |
Monitor for symptoms. Detection usually by direct microscopic observation of oocysts
in stool specimens. Nucleic acid and antigen detection methods have also been developed
|
MSU Requirements | Report any exposures |
Laboratory Acquired Infections (LAIs) | High risk of infection. At least 16 cases laboratory acquired infections have been
reported.
|
---|---|
Sources |
Stool, intestinal biopsy specimens from humans or animals and environmental water.
Cultures, frozen stocks, other samples described in IBC protocol.
|
Canadian MSDS: | http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-eng.php |
---|---|
BMBL
|
https://www.cdc.gov/labs/bmbl/?CDC_AAref_Val=https://www.cdc.gov/labs/BMBL.html |
CDC | |
NIH Guidelines |
Risk Group 2
|
Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available. |
---|---|
BSL2
|
For all procedures involving suspected or known infectious specimen or cultures.
|
ABSL2
|
For all procedures utilizing infected animals.
|
Small
|
Notify others working in the lab. Remove PPE and don new PPE. Cover area of the spill
with absorbent material and add fresh 1:10 bleach:water. Allow 20 munutes (or as directed)
of contact time. After 20 minutes, cleanup and dispose of materials.
|
---|---|
Large
|
|
Mucous membrane
|
Flush eyes, mouth, or nose for 5 minutes at eyewash station.
|
---|---|
Other Exposures
|
Wash area with soap and water for 5 minutes.
|
Reporting |
Immediately report incident to supervisor, complete a First Report of Injury form, and submit to Safety and Risk Management.
|
Medical Follow-up
|
During business hours: Bridger Occupational Health 3406 Laramie Drive. Weekdays 8am -6pm. Weekends 9am-5pm
After business hours: Bozeman Deaconess Hospital Emergency Room 915 Highland Blvd Bozeman, MT |
Disinfection |
1:2 bleach:water, accelerated hydrogen peroxide
|
---|---|
Inactivation |
Inactivated by moist heat (121°C for 30 minutes)
|
Survival Outside Host |
Can survive for at least 6 months in the environment
|
Minimum PPE Requirements
|
Lab coat, disposable gloves, safety glasses, closed toed shoes, long pants
|
---|---|
Additional Precautions
|
Additioanl PPE may be required depending on lab specific SOPs and IBC Protocol. |